GSK2801
GSK2801 is a potent and selective cell-active inhibitor targeting the BAZ2A (Kd=136 nM) and BAZ2B (Kd=257 nM) bromodomains by competing with acetylated lysine. This tool compound is used in vitro to study bromodomain function in areas such as cancer biology and chromatin remodeling.
Product Specifications
CAS Number
1619994-68-1
Product Name Alternative
TNBC, cetyl-lysine, Apoptosis, BAZ2A, BAZ2B, Inhibitor, EpigeneticReaderDomain, Epigenetic Reader Domain, GSK 2801, GSK2801, GSK-2801, inhibit, orally
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
97.78% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.38 mM) ; DMSO:18.6 mg/mL (50.07 mM)
Smiles
CCCOc1ccn2c (cc (-c3ccccc3S (C) (=O) =O) c2c1) C (C) =O
Molecular Formula
C20H21NO4S
Molecular Weight
371.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![CD25 Antibody [3C7] (PE-Cy7)](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
bs-13709R-BF647 100 µL
TMPO Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details 